These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36276157)

  • 1. Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential.
    Luo M; Chen X; Gao H; Yang F; Chen J; Qiao Y
    Front Oncol; 2022; 12():980111. PubMed ID: 36276157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria.
    Kang SR; Min JJ
    Nucl Med Mol Imaging; 2021 Feb; 55(1):7-14. PubMed ID: 33643484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella as an innovative therapeutic antitumor agent.
    Chang WW; Lee CH
    Int J Mol Sci; 2014 Aug; 15(8):14546-54. PubMed ID: 25196596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological Mechanism and Clinical Application of PAMP Adjuvants.
    Yan Y; Yao D; Li X
    Recent Pat Anticancer Drug Discov; 2021; 16(1):30-43. PubMed ID: 33563182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy.
    Chen W; Zhu Y; Zhang Z; Sun X
    Adv Drug Deliv Rev; 2022 Jun; 185():114295. PubMed ID: 35429576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of
    Badie F; Ghandali M; Tabatabaei SA; Safari M; Khorshidi A; Shayestehpour M; Mahjoubin-Tehran M; Morshedi K; Jalili A; Tajiknia V; Hamblin MR; Mirzaei H
    Front Oncol; 2021; 11():624759. PubMed ID: 33738260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteria and bacterial derivatives as drug carriers for cancer therapy.
    Cao Z; Liu J
    J Control Release; 2020 Oct; 326():396-407. PubMed ID: 32681947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
    Zhang M; Kim JA; Huang AY
    Front Immunol; 2018; 9():341. PubMed ID: 29535722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma.
    Wang C; Shi X; Song H; Zhang C; Wang X; Huang P; Dong A; Zhang Y; Kong D; Wang W
    Biomaterials; 2021 Jan; 268():120579. PubMed ID: 33278683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.
    Harisa GI; Sherif AY; Youssof AME; Alanazi FK; Salem-Bekhit MM
    AAPS PharmSciTech; 2020 Jun; 21(5):168. PubMed ID: 32514657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterials-Based Delivery of Therapeutic Antibodies for Cancer Therapy.
    Ye QN; Wang Y; Shen S; Xu CF; Wang J
    Adv Healthc Mater; 2021 Jun; 10(11):e2002139. PubMed ID: 33870637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Bacteria-Based Cancer Treatment.
    Wei X; Du M; Chen Z; Yuan Z
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunogenic potential of bacterial flagella for Salmonella-mediated tumor therapy.
    Felgner S; Spöring I; Pawar V; Kocijancic D; Preusse M; Falk C; Rohde M; Häussler S; Weiss S; Erhardt M
    Int J Cancer; 2020 Jul; 147(2):448-460. PubMed ID: 31755108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria and cancer: Different sides of the same coin.
    Laliani G; Ghasemian Sorboni S; Lari R; Yaghoubi A; Soleimanpour S; Khazaei M; Hasanian SM; Avan A
    Life Sci; 2020 Apr; 246():117398. PubMed ID: 32032647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant.
    Felgner S; Frahm M; Kocijancic D; Rohde M; Eckweiler D; Bielecka A; Bueno E; Cava F; Abraham WR; Curtiss R; Häussler S; Erhardt M; Weiss S
    mBio; 2016 Sep; 7(5):. PubMed ID: 27601574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope.
    Lou X; Chen Z; He Z; Sun M; Sun J
    Nanomicro Lett; 2021 Jan; 13(1):37. PubMed ID: 34138211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.